• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX (TRIVASCULAR) OVATION IX; AORTIC MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX (TRIVASCULAR) OVATION IX; AORTIC MAIN BODY Back to Search Results
Model Number TV-AB2380-J
Medical Device Problem Codes Fluid/Blood Leak (1250); Material Integrity Problem (2978)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Failure of Implant (1924)
Date of Event 05/16/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The lot history records related to the subject device referenced in this complaint record were reviewed for potential contributing factors for the failure mode(s) described in this event.A review of the device quality records showed that the device(s) demonstrated compliance to established procedures and specifications at the time of manufacture.
 
Event or Problem Description
An ovation ix abdominal stent graft system was implanted to treat an abdominal aortic aneurysm.A suspected polymer leak may have occurred however, the patient remained stable with no hypotensive reaction or treatment.A palmaz stent was implanted and the aneurysm was successfully excluded.The patient will continue to be monitored.
 
Additional Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The returned delivery system is not applicable/germane to the reported hypotension due to a suspected polymer leak as outlined within the endologix field safety notice (fsn), fs-0012.Technical and procedural factors of the user (e.G.Use of the cross over lumen before polymer fill, catheter manipulation) are not causative for the majority of polymer leaks as was previously communicated, subsequently an evaluation of the returned delivery system is no longer warranted.At the completion of the clinical assessment, the patient experienced hypotension and was successfully treated for an anaphylactic reaction per the device ifu due to a suspected polymer leak was confirmed.This event is most likely device related as identified in field safety notice (fs-0012), the root cause for most polymer leaks is a material weakness adjacent to the polymer fill channel which may become compromised during pressurization with liquid polymer.Since this device remains implanted, endologix is unable to conduct product evaluation to conclusively ascertain root cause.However, based on the investigation associated with the fsn this is the most likely cause associated with this event.The final patient status was reported being stable.On 06aug2018, endologix issued a field safety notice (fs-0009) regarding the risk of polymer leak events with the ovation ix aortic body stent graft.On 06may2020, endologix issued a follow-up safety update (fs-0012) reaffirming treatment recommendations for patients who experience a polymer leak during implantation and providing updated information on the current rate of polymer leaks, the rate of clinical harms and root cause.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Event or Problem Description
The patient was initially implanted with the ovation ix abdominal stent graft system to treat an abdominal aortic aneurysm (aaa).Post polymer fill of the aortic body stent graft, the patient experienced hypotension due to a suspected polymer leak and was successfully treated for an anaphylactic reaction per the device ifu.A palmaz (non- endologix) stent was required but no endoleak was identified.At the conclusion of the procedure the aneurysm was excluded.The patient will continue to be monitored.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
AORTIC MAIN BODY
Manufacturer (Section D)
ENDOLOGIX (TRIVASCULAR)
3910 brickway blvd
santa rosa CA 95403
MDR Report Key8697929
Report Number3008011247-2019-00095
Device Sequence Number19401665
Product Code MIH
UDI-Device IdentifierM701TVAB2380J1
UDI-Public+M701TVAB2380J1/$$3220320FS03151902Z
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup
Report Date (Section B) 05/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/20/2022
Device Model NumberTV-AB2380-J
Device Catalogue NumberTV-AB2380-J
Device Lot NumberFS031519-02
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/16/2019
Supplement Date Received by Manufacturer05/16/2019
Initial Report FDA Received Date06/13/2019
Supplement Report FDA Received Date08/30/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
FSN-0009, FSN-0012
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OVATION IX ILIAC LIMB - FS100818-23; OVATION IX ILIAC LIMB - FS102318-10; OVATION PRIME POLYMER - FF102418-03
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
-
-